Protein (2)
Launched (2)
Human (2)
Fc Tag (1)His Tag (1)
Unconjugated (2)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|---|
CX2-H5253 | HEK293 | Human CXCL2 Protein, Fc Tag (MALS & SPR verified) | ![]() | |||
CX2-H52H3 | HEK293 | Human CXCL2 Protein, His Tag | ![]() |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Asunercept | CAN-008; APG-101 | Phase 2 Clinical | Apogenix Gmbh | Glioblastoma; Myelodysplastic Syndromes; Coronavirus Disease 2019 (COVID-19) | Details |
| M3T01 | M3T01 | Phase 1 Clinical | Providence Health & Services | Solid tumours | Details |

BettinastraBe 30, 60325 Frankfurt am Main





